263 related articles for article (PubMed ID: 20600486)
21. A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain.
Weiss M; Brum MC; Anziliero D; Weiblen R; Flores EF
Braz J Med Biol Res; 2015 Sep; 48(9):843-51. PubMed ID: 26200229
[TBL] [Abstract][Full Text] [Related]
22. Safety aspects in the development of an infectious bovine rhinotracheitis marker vaccine.
Strube W; Abar B; Bergle RD; Block W; Heinen E; Kretzdorn D; Rodenbach C; Schmeer N
Dev Biol Stand; 1995; 84():75-81. PubMed ID: 7796970
[TBL] [Abstract][Full Text] [Related]
23. Immunization against bovine herpesvirus-1 infection. Preliminary tests in calves with a DNA vaccine.
Castrucci G; Ferrari M; Marchini C; Salvatori D; Provinciali M; Tosini A; Petrini S; Sardonini Q; Lo Dico M; Frigeri F; Amici A
Comp Immunol Microbiol Infect Dis; 2004 May; 27(3):171-9. PubMed ID: 15001312
[TBL] [Abstract][Full Text] [Related]
24. Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1.
Toussaint JF; Letellier C; Paquet D; Dispas M; Kerkhofs P
Vaccine; 2005 Oct; 23(43):5073-81. PubMed ID: 16024138
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant effect of green propolis on humoral immune response of bovines immunized with bovine herpesvirus type 5.
Fischer G; Cleff MB; Dummer LA; Paulino N; Paulino AS; de Oliveira Vilela C; Campos FS; Storch T; D'Avila Vargas G; de Oliveira Hübner S; Vidor T
Vet Immunol Immunopathol; 2007 Mar; 116(1-2):79-84. PubMed ID: 17275918
[TBL] [Abstract][Full Text] [Related]
26. Immune responses in bovines to recombinant glycoprotein D of bovine herpesvirus type 5 as vaccine antigen.
Araujo IL; Dummer LA; Rodrigues PRC; Dos Santos AG; Fischer G; Cunha RC; Leite FPL
Vaccine; 2018 Nov; 36(50):7708-7714. PubMed ID: 30381153
[TBL] [Abstract][Full Text] [Related]
27. Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1.
Gogev S; de Fays K; Versali MF; Gautier S; Thiry E
Vaccine; 2004 May; 22(15-16):1946-53. PubMed ID: 15121307
[TBL] [Abstract][Full Text] [Related]
28. Bovine herpesvirus type 1 marker vaccine induces cross-protection against bubaline herpesvirus type 1 in water buffalo.
Montagnaro S; De Martinis C; Iovane V; Ciarcia R; Damiano S; Nizza S; De Martino L; Iovane G; Pagnini U
Prev Vet Med; 2014 Sep; 116(1-2):56-62. PubMed ID: 24985155
[TBL] [Abstract][Full Text] [Related]
29. Clinical protection against caprine herpesvirus 1 genital infection by intranasal administration of a live attenuated glycoprotein E negative bovine herpesvirus 1 vaccine.
Thiry J; Tempesta M; Camero M; Tarsitano E; Muylkens B; Meurens F; Thiry E; Buonavoglia C
BMC Vet Res; 2007 Dec; 3():33. PubMed ID: 18053233
[TBL] [Abstract][Full Text] [Related]
30. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine.
Kaashoek MJ; Moerman A; Madić J; Rijsewijk FA; Quak J; Gielkens AL; van Oirschot JT
Vaccine; 1994 Apr; 12(5):439-44. PubMed ID: 8023552
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
[TBL] [Abstract][Full Text] [Related]
32. Strategies for induction of protective immunity to bovine herpesvirus-1 in newborn calves with maternal antibodies.
van Drunen Littel-van den Hurk S; Snider M; Thompson P; Latimer L; Babiuk LA
Vaccine; 2008 Jun; 26(25):3103-11. PubMed ID: 18433948
[TBL] [Abstract][Full Text] [Related]
33. A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs.
Strube W; Auer S; Block W; Heinen E; Kretzdorn D; Rodenbach C; Schmeer N
Vet Microbiol; 1996 Nov; 53(1-2):181-9. PubMed ID: 9011010
[TBL] [Abstract][Full Text] [Related]
34. Protective immunity following vaccination with a recombinant multiple-epitope protein of bovine herpesvirus type I in a rabbit model.
Wen X; Tong X; Wang M; Wang J; Ni H; Ran X
Appl Microbiol Biotechnol; 2020 Apr; 104(7):3011-3023. PubMed ID: 32002602
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of safety and efficacy of DNA vaccines against bovine herpesvirus-1 (BoHV-1) in calves.
Petrini S; Ramadori G; Corradi A; Borghetti P; Lombardi G; Villa R; Bottarelli E; Guercio A; Amici A; Ferrari M
Comp Immunol Microbiol Infect Dis; 2011 Jan; 34(1):3-10. PubMed ID: 19906427
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of a temperature-sensitive modified-live bovine herpesvirus type-1 vaccine against abortion and stillbirth in pregnant heifers.
Cravens RL; Ellsworth MA; Sorensen CD; White AK
J Am Vet Med Assoc; 1996 Jun; 208(12):2031-4. PubMed ID: 8707679
[TBL] [Abstract][Full Text] [Related]
37. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
[TBL] [Abstract][Full Text] [Related]
38. Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants.
Kaashoek MJ; van Engelenburg FA; Moerman A; Gielkens AL; Rijsewijk FA; van Oirschot JT
Vet Microbiol; 1996 Jan; 48(1-2):143-53. PubMed ID: 8701570
[TBL] [Abstract][Full Text] [Related]
39. Long-term study (2005-2010) on the vaccination with BoHV-1 glycoprotein E-deleted marker vaccine in selected two dairy herds in Turkey.
Alkan F; Bilge-Dagalp S; Karapınar Z; Timurkan MO; Coskun N; Burgu I
Trop Anim Health Prod; 2018 Feb; 50(2):353-363. PubMed ID: 29071668
[TBL] [Abstract][Full Text] [Related]
40. A bovine herpesvirus 5 recombinant defective in the thymidine kinase (TK) gene and a double mutant lacking TK and the glycoprotein E gene are fully attenuated for rabbits.
Silva SC; Brum MC; Weiblen R; Flores EF; Chowdhury SI
Braz J Med Biol Res; 2010 Feb; 43(2):150-9. PubMed ID: 20027480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
